Stocks · Health care · Biological Products, (No Diagnostic Substances)

ADMA BIOLOGICS, INC.

ADMA Clue Score77
United States Fiscal year ends December CIK 0001368514 Results filed 4 Nov 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Lawrence P. Guiheen
13 Mar 2026
Director
Exercised, kept
30,000
$3.66
$109.80K
Kaitlin M. Kestenberg-Messina
30 Jul 2025
COO and SVP, Compliance
Exercised, kept
2,500
$8.98
$22.45K
Kaitlin M. Kestenberg-Messina
30 Jan 2025
COO and SVP, Compliance
Exercised, kept
5,000
$10.80
$54.00K
Steve Elms
27 Nov 2024
Director
Exercised, kept indirect
9,000
$10.80
$97.20K
Eric I Richman
13 Jul 2017
Director
Exercised, kept
2,800
$2.68
$7.50K
Jerrold B Grossman
13 Jul 2017
Director
Exercised, kept
48,185
$2.68
$129.14K
Adam S Grossman
13 Jul 2017
President and CEO
Exercised, kept
42,021
$2.68
$112.62K

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 38
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 15,523,958
Sales filed before the plan box existed 12
History held since 13 Feb 2012